Kadura S, Raghu G. Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management. Eur Respir Rev. 2021;30(160):210011.

PubMed  PubMed Central  Google Scholar 

Koduri G, Solomon JJ. Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2023;75(12):2067–77

PubMed  Google Scholar 

Juge PA, Granger B, Debray MP, Ebstein E, Louis-Sidney F, Kedra J, Doyle TJ, Borie R, Constantin A, Combe B, et al. A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2022;74(11):1755–65.

PubMed  PubMed Central  Google Scholar 

Narvaez J, Aburto M, Seoane-Mato D, Bonilla G, Acosta O, Candelas G, Cano-Jimenez E, Castellvi I, Gonzalez-Ruiz JM, Corominas H, et al. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatol Clin (Engl Ed). 2023;19(2):74–81.

PubMed  Google Scholar 

Paulin F, Doyle TJ, Mercado JF, Fassola L, Fernandez M, Caro F, Alberti ML, Espindola MEC, Buschiazzo E. Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis. Reumatol Clin (Engl Ed). 2021;17(4):207–11.

PubMed  Google Scholar 

Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, et al. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. N Engl J Med. 2018;379(23):2209–19.

CAS  PubMed  PubMed Central  Google Scholar 

Xue J, Hu W, Wu S, Wang J, Chi S, Liu X. Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis. Front Immunol. 2022;13: 823669.

CAS  PubMed  PubMed Central  Google Scholar 

Koduri GM, Podlasek A, Pattapola S, Zhang J, Laila D, Nandagudi A, Dubey S, Kelly C. Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis. Rheumatol Int. 2023;43(8):1515–23.

PubMed  PubMed Central  Google Scholar 

Samhouri BF, Vassallo R, Achenbach SJ, Kronzer VL, Davis JM 3rd, Myasoedova E, Crowson CS. Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort. Arthritis Care Res (Hoboken). 2022;74(12):2042–9.

CAS  PubMed  Google Scholar 

Matteson EL, Matucci-Cerinic M, Kreuter M, Burmester GR, Dieude P, Emery P, Allanore Y, Pope J, Khanna D. Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD Open. 2023;9(3):e003059.

PubMed  PubMed Central  Google Scholar 

Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, et al. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. Am J Respir Crit Care Med. 2015;191(12):1403–12.

CAS  PubMed  PubMed Central  Google Scholar 

Fan W, Chen J, Bao C. An updated meta-analysis of association of rheumatoid arthritis related interstitial lung disease with anti-cyclic citrullinated peptide antibody or rheumatoid factor. Int J Clin Exp Med. 2016;9(6):10333–43.

CAS  Google Scholar 

Kamiya H, Panlaqui OM. Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody. BMJ Open. 2021;11(3): e040465.

PubMed  PubMed Central  Google Scholar 

Xie S, Li S, Chen B, Zhu Q, Xu L, Li F. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis. Clin Rheumatol. 2021;40(11):4533–43.

PubMed  Google Scholar 

Zhang M, Yin J, Zhang X. Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis. PLoS ONE. 2023;18(6): e0286191.

CAS  PubMed  PubMed Central  Google Scholar 

Zhu J, Zhou Y, Chen X, Li J. A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J Rheumatol. 2014;41(7):1282–9.

PubMed  Google Scholar 

Borenstein M. Introduction to meta-analysis. Chichester, U.K.: John Wiley & Sons; 2009.

Google Scholar 

Morton SC, Murad MH, O’Connor E, Lee CS, Booth M, Vandermeer BW, Snowden JM, D’Anci KE, Fu R, Gartlehner G, et al. Quantitative Synthesis—An Update. In: Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. Rockville (MD), Agency for Healthcare Research and Quality (US). 2008. PMID: 30125065.

van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21(4):589–624.

PubMed  Google Scholar 

Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1–48.

Google Scholar 

Williams DR, Rodriguez JE, Bürkner P-C. Putting variation into variance: Modeling between-study heterogeneity in Meta-Analysis. PsyArXiv. 2021. https://doi.org/10.31234/osf.io/9vkqy.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA. Brennan SE et al: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;29:372.

Google Scholar 

Alemao E, Doyle T, Sparks J, Rao A, Saini Y, Iannaccone C, Weinblatt ME, Shadick N: Sat0072 Evaluation of Rheumatoid Arthritis Treatments and Joint Outcomes in Rheumatoid Arthritis-Associated Interstitial Lung Disease. In: Saturday, 15 June 2019. 2019: 1099.1092–1100.

Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN, Dawson J, Sathi N, Ahmad Y, Koduri G, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics–a large multicentre UK study. Rheumatology (Oxford). 2014;53(9):1676–82.

CAS  PubMed  Google Scholar 

Hedstrom AK, Ronnelid J, Klareskog L, Alfredsson L. Complex Relationships of Smoking, HLA-DRB1 Genes, and Serologic Profiles in Patients With Early Rheumatoid Arthritis: Update From a Swedish Population-Based Case-Control Study. Arthritis Rheumatol. 2019;71(9):1504–11.

PubMed  PubMed Central  Google Scholar 

Regueiro C, Rodriguez-Martinez L, Nuno L, Ortiz AM, Villalba A, Pascual-Salcedo D, Martinez-Feito A, Gonzalez-Alvaro I, Balsa A, Gonzalez A. Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics. Arthritis Res Ther. 2019;21(1):280.

CAS  PubMed  PubMed Central  Google Scholar 

Verheul MK, Bohringer S, van Delft MAM, Jones JD, Rigby WFC, Gan RW, Holers VM, Edison JD, Deane KD, Janssen KMJ, et al. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals. Arthritis Rheumatol. 2018;70(11):1721–31.

CAS  PubMed  Google Scholar 

Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):226.

PubMed  PubMed Central  Google Scholar 

Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, Finzel S, Schett G. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis. 2015;74(12):2151–6.

CAS  PubMed  Google Scholar 

Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM, Michaud K, Sayles H, Reimold AM, Caplan L, et al. Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(4):813–21.

CAS  PubMed  PubMed Central  Google Scholar 

Lingampalli N, Sokolove J, Lahey LJ, Edison JD, Gilliland WR, Holers VM, Deane KD, Robinson WH. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis. Clin Immunol. 2018;195:119–26.

CAS  PubMed  Google Scholar 

Sparks JA, Dieude P, Hoffmann-Vold AM, Burmester GR, Walsh SL, Kreuter M, Stock C, Sambevski S, Alves M, Emery P. Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis. BMC Rheumatol. 2024;8(1):19.

PubMed  PubMed Central  Google Scholar 

Wang D, Zhang J, Lau J, Wang S, Taneja V, Matteson EL, Vassallo R. Mechanisms of lung disease development in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15(10):581–96.

PubMed  Google Scholar 

Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest. 2006;116(12):3183–94.

CAS  PubMed  PubMed Central  Google Scholar 

Reynisdottir G, Olsen H, Joshua V, Engstrom M, Forsslund H, Karimi R, Skold CM, Nyren S, Eklund A, Grunewald J, et al. Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis. Ann Rheum Dis. 2016;75(9):1722–7.

CAS  PubMed  Google Scholar 

Demoruelle MK, Bowers E, Lahey LJ, Sokolove J, Purmalek M, Seto NL, Weisman MH, Norris JM, Kaplan MJ, Holers VM, et al. Antibody Responses to Citrullinated and Noncitrullinated Antigens in the Sputum of Subjects With Rheumatoid Arthritis and Subjects at Risk for Development of Rheumatoid Arthritis. Arthritis Rheumatol. 2018;70(4):516–27.

CAS  PubMed  PubMed Central  Google Scholar 

Reynisdottir G, Karimi R, Joshua V, Olsen H, Hensvold AH, Harju A, Engstrom M, Grunewald J, Nyren S, Eklund A, et al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 2014;66(1):31–9.

CAS  PubMed  Google Scholar 

England BR, Duryee MJ, Roul P, Mahajan TD, Singh N, Poole JA, Ascherman DP, Caplan L, Demoruelle MK, Deane KD, et al. Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheuma